Extensive peer-reviewed research has identified biologically active nutrients and biochemical intermediates that play ...

The emergence of AI and biosensors offers a chance to address inefficiencies in drug development.

Angela Zubel, chief development officer, Debiopharm, discusses why 2026 marks a shift from AI pilots to broader operational ...

BioPhy announces acquisition by Intrinsic Clinical Systems. The AI-driven platform will continue advancing quality and ...

OncoRes Medical has initiated a clinical trial involving six hospitals in Western Australia and Victoria.

Recent developments in the biopharma AI world include an alliance between Thermo and Datavant, plus news from Insilico, ...

Thermo Fisher Scientific has entered into a strategic data collaboration with Datavant aimed at expanding real-world data (RWD) interoperability and linkage across clinical research and development ...

Even when promising clinical trials exist, and the FDA allows expanded access, rare disease patients like my granddaughter ...

Roy W. Ware, PhD, MBA appointed as Chief Manufacturing and Technology OfficerCaryn Barnett appointed as VP, Clinical ...

Over the past decade, a shift has been occurring in biopharma R&D. Despite great advancements in drug technologies and our understanding of diseases, it is getting harder to develop new drugs and ...